Akebia Therapeutics
AKBA
AKBA
164 hedge funds and large institutions have $263M invested in Akebia Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 68 increasing their positions, 43 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
45% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 53
83% less capital invested
Capital invested by funds: $1.52B → $263M (-$1.25B)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
164
Holding in Top 10
–
Calls
$5.32M
Puts
$2.15M
Top Buyers
| 1 | +$25.9M | |
| 2 | +$18.4M | |
| 3 | +$12.1M | |
| 4 |
Morgan Stanley
New York
|
+$2.48M |
| 5 |
Squarepoint
New York
|
+$2.34M |
Top Sellers
| 1 | -$204M | |
| 2 | -$95.5M | |
| 3 | -$47.7M | |
| 4 |
ClearBridge Investments
New York
|
-$20.7M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$16.3M |